Venous Thromboembolism Patients with Anticoagulation Overlap Therapy (211)    NLM QUALITY MEASURE GROUPS (802.3)

Name Value
MEASURE TITLE Venous Thromboembolism Patients with Anticoagulation Overlap Therapy
CMS ID CMS73v2
VERSION NUMBER 2
SHEETNAME VTE 3
DEVELOPER Joint Commission
STEWARD Joint Commission
COPYRIGHT
Measure specifications are in the Public Domain.
VALUE SETS
  • VALUE SET OID:   2.16.840.1.114222.4.11.837
    VALUE SET VERSION DATE:   2012-10-25 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.117.1.7.1.23
    VALUE SET VERSION DATE:   2013-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.117.1.7.1.308
    VALUE SET VERSION DATE:   2013-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.117.1.7.1.473
    VALUE SET VERSION DATE:   2013-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.117.1.7.1.264
    VALUE SET VERSION DATE:   2013-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.117.1.7.1.134
    VALUE SET VERSION DATE:   2013-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.526.2.1076
    VALUE SET VERSION DATE:   2013-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.117.1.7.1.266
    VALUE SET VERSION DATE:   2013-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.117.1.7.1.309
    VALUE SET VERSION DATE:   2013-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.117.1.7.1.93
    VALUE SET VERSION DATE:   2013-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.117.1.7.1.407
    VALUE SET VERSION DATE:   2013-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113762.1.4.1
    VALUE SET VERSION DATE:   2012-10-25 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.117.1.7.1.276
    VALUE SET VERSION DATE:   2013-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.117.1.7.1.279
    VALUE SET VERSION DATE:   2013-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.117.1.7.1.232
    VALUE SET VERSION DATE:   2013-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.560.100.4
    VALUE SET VERSION DATE:   2013-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.114222.4.11.3591
    VALUE SET VERSION DATE:   2012-10-25 00:00:00
  • VALUE SET OID:   2.16.840.1.114222.4.11.836
    VALUE SET VERSION DATE:   2012-10-25 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.117.1.7.1.87
    VALUE SET VERSION DATE:   2013-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.117.1.7.1.207
    VALUE SET VERSION DATE:   2013-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.117.1.7.1.209
    VALUE SET VERSION DATE:   2013-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.117.1.7.1.293
    VALUE SET VERSION DATE:   2013-04-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.117.1.7.1.213
    VALUE SET VERSION DATE:   2013-04-01 00:00:00
GUID 6f069bb2-b3c4-4bf4-adc5-f6dd424a10b7
NQF NUMBER 0373
DESCRIPTION
This measure assesses the number of patients diagnosed with confirmed VTE 
who received an overlap of parenteral (intravenous [IV] or subcutaneous 
[subcu]) anticoagulation and warfarin therapy. For patients who received 
less than five days of overlap therapy, they should be discharged on both 
medications or have a reason for discontinuation of overlap therapy. Overlap 
therapy should be administered for at least five days with an international 
normalized ratio (INR) greater than or equal to 2 prior to discontinuation 
of the parenteral anticoagulation therapy, discharged on both medications 
or have a reason for discontinuation of overlap therapy.
CATEGORY Individual Characteristic
IDENTIFIER 73
STATUS Complete
TYPE PROCESS
MEASURE SET FY 2014 EH